FindTrial
Sign In

LH based flexible GnRH antagonist protocol in women with normal ovarian response undergoing in vitro fertilization and embryo transfer: a randomized controlled trial

a more flexible GnRH antagonist protocol in women with normal ovarian response undergoing in vitro fertilization and embryo transfer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018077
Enrollment
Unknown
Registered
2018-08-29
Start date
2018-10-01
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Group 2:traditional flexible GnRH antagonist protocol
Group 1:more flexible GnRH antagonist protocol based on LH level

Sponsors

Beijing Chaoyang Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged 23-35 years; 2. Regular menstrual cycles; 3. basal FSH < 10IU/L,AFC8-20; 4. BMI18-23kg/m2; 5. The subjects must be volunteers and sign informed consents in person or by the legal representative.

Exclusion criteria

Exclusion criteria: 1. Polycystic ovarian syndrome; 2. ultrasound or hysteroscopy indicated intrauterine or endometrial lesion, including uterine malformation, endometrial polyp, hyperplasia, intrauterine adhesion, etc; 3. endometriosis, adenomyosis; 4. medical comorbidities like diabetes mellitus.

Design outcomes

Primary

MeasureTime frame
Cumulative ongoing pregnancy rate per cycle;the OHSS rate;—

Secondary

MeasureTime frame
clinical pregnancy rate;good quality embryos rate;—

Countries

China

Contacts

Public ContactYuan Li

Beijing Chaoyang Hospital affiliated to Capital Medical University

sdliyuan@126.com+86 010-85231423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026